Bharat Parenterals Ratios

Bharat Parenterals Ltd Ratios

The Bharat Parenterals Ltd Ratios page provides a complete fundamental analysis of Bharat Parenterals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Bharat Parenterals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Bharat Parenterals Ltd (NSE: , BSE: 541096) is currently trading at ₹1084.90, with a market capitalization of ₹7.16B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Bharat Parenterals Ltd remains a key stock for fundamental analysis using Bharat Parenterals Ltd Ratios.

Bharat Parenterals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Bharat Parenterals Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Bharat Parenterals Ltd Ratios.

Historically, the Bharat Parenterals Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 45
• 2022: 11.80
• 2021: 9.31
• 2020: 9.42

The decline in Bharat Parenterals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Bharat Parenterals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.95.

Historical P/B trend:

• 2024: 1.95
• 2023: 3.31
• 2022: 1.07
• 2021: 1.19

Bharat Parenterals Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Bharat Parenterals Ltd P/S ratio currently stands at 1.92, an important part of Bharat Parenterals Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.92
• 2023: 2.52
• 2022: 0.89
• 2021: 0.92

A stable or declining Bharat Parenterals Ltd P/S ratio indicates cautious market sentiment.

Bharat Parenterals Ltd Price to Cash Flow Ratio (P/CF)

The Bharat Parenterals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Bharat Parenterals Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 9.34
• 2021: 0
• 2020: 6.27

The declining Bharat Parenterals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Bharat Parenterals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Bharat Parenterals Ltd EV currently stands at ₹7.73B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 7.73B
• 2023: 8.37B
• 2022: 2.69B
• 2021: 2.02B

Bharat Parenterals Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Bharat Parenterals Ltd EV/EBITDA ratio is currently 529.11, a key metric in Bharat Parenterals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 529.11
• 2023: 31.84
• 2022: 12.73
• 2021: 6.88

Higher Bharat Parenterals Ltd EV/EBITDA suggests premium valuation.

Bharat Parenterals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Bharat Parenterals Ltd D/E ratio is currently 0.54, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.54
• 2023: 0.80
• 2022: 0.27
• 2021: 0.11

Bharat Parenterals Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Bharat Parenterals Ltd ROE currently stands at -4.78%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -4.78
• 2023: 7.64
• 2022: 9.43
• 2021: 13.60

Declining ROE indicates pressure on profitability.

Bharat Parenterals Ltd Ratios Analysis Summary

The Bharat Parenterals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Bharat Parenterals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Bharat Parenterals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.